Serum VEGF and COX-2/5LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304. Results: Through 12/0930 pts (F = 13, M = 17) enrolled. At baseline men had higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results